A non-ablative treatment for benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) achieved durable ...
FMJ Debruyne, A.A. Gres, A. Bantschev, M. Tzvetkov, K. Grdovic, the poster referred to previously disclosed results from two Phase 2 trials with cetrorelix in benign prostatic hyperplasia (BPH), which ...
Dr. Steven A. Kaplan presented positive 4-year and 12-month clinical outcomes during the American Urological Association's Annual Meeting "The positive data from the PINNACLE and EVEREST trials – ...
The 2026 European Association of Urology (EAU) annual meeting featured a plenary prostate cancer session and a presentation by Dr. Jozefina Casuscelli discussing the optimal management of de-novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results